论文信息 - A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma. - 字舞流文

A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Shing M. Lee | G. Schwartz | Tahir N. Sheikh | R. Piekarz | M. Ingham | W. Chow | Mia C. Weiss | B. Siontis | Benjamin Powers | Jay Oza | Wendy Magana